Active Not RecruitingNCT06324435
Apremilast for Addiction Treatment in Women and Men
Medication studyAges 21–65United States
Understand this study
Who could participate?
Listed age limits: 21 years to 65 years.
- Listed locations
- New HavenSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 8, 2024
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 10
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 21 Years to 65 Years
- Official registry ID
- NCT06324435
- Official title
Show the full official title
Apremilast for Alcohol Use Disorder Treatment in Women and Men
Recruitment & locations
Not recruitingNew Haven
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Does this study involve medication?
Yes. The study involves medication, including Apremilast.
Who can participate?
Listed age limits: 21 years to 65 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
